Héloïse Boullet

Innovation Manager at Amolyt Pharma

Héloïse Boullet has a diverse work experience spanning various industries and roles. Héloïse currently works as an Innovation Manager at Amolyt Pharma since June 2020. Prior to that, they worked at EIF Innovation as a Expert Consultant in Innovation Financing from May 2018 to May 2020. Héloïse also has experience as a Consultant in Innovation Financing at FRS Consulting from February 2015 to May 2018. Héloïse worked at University P.Curie UPMC-Paris6, where they served as a Business Manager in Research Valorization from October 2013 to February 2015, and as a Technology Transfer and Valorization Officer from October 2010 to September 2013. Furthermore, they were a Project Manager in Chemistry at Université Pierre et Marie Curie - ENS from September 2010 to September 2013. Héloïse also completed a research internship in organic synthesis at Institut De Recherche Servier from March 2010 to August 2010. Prior to their career in the science sector, Héloïse worked as a Sales Advisor in Telephony and Internet at France Telecom from November 2008 to October 2009. Héloïse also gained experience as a Laboratory Technician Trainee at ICCOM in Florence, Italy, from February 2007 to April 2007, where they conducted various tasks such as communication in English and the synthesis of aziridine.

Héloïse Boullet began their education in 2005 at IUT de Rouen, where they earned a DUT in Chemistry, completing their studies in 2007. Héloïse then attended Heriot-Watt University in 2007-2008, where they completed a Bachelor of Sciences in Chemistry. From 2008 to 2010, they studied at Université de Rouen, obtaining a Master's degree in Chemistry and Physico-Chemistry of Medicines. Héloïse then pursued further studies at Pierre and Marie Curie University, completing a DU in Biological and Medical Engineering in 2010-2011 and a Doctorate in Organic Chemistry from 2010 to 2013.

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Amolyt Pharma

Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders. Its programs include AZP-3601, a parathyroid hormone analog, for the potential treatment of hypoparathyroidism, and AZP-3404, a peptide with a new and unique mechanism of action, that may restore fat and glucose metabolism.


Headquarters

Écully, France

Employees

11-50

Links